Sit Investment Associates’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,614
Closed -$835K 546
2017
Q4
$835K Buy
10,614
+5,665
+114% +$457K 0.02% 385
2017
Q3
$416K Buy
4,949
+260
+6% +$18.4K 0.01% 434
2017
Q2
$307K Hold
4,689
0.01% 449
2017
Q1
$341K Hold
4,689
0.01% 439
2016
Q4
$275K Buy
+4,689
New +$248K 0.01% 406

Other funds holding ADNT

Sit Investment Associates's ADNT Position: Q1 2018 in Review

Sit Investment Associates sold out of Adient (ADNT) in Q1 2018, closing a stake of 10,614 shares — an estimated $835K sold.

Sit Investment Associates first reported a position in ADNT in Q4 2016 and held it in 5 quarters. The position peaked at $835K in Q4 2017. 401 funds tracked by Wall St. Rank hold ADNT as of Q1 2018.

  • Sit Investment Associates reported no remaining Adient position as of Q1 2018 after selling out during the quarter.
  • Sit Investment Associates sold 10,614 Adient shares in Q1 2018, an estimated $835K.
  • Sit Investment Associates first reported a position in Adient in Q4 2016 and held it in 5 quarters.
  • Sit Investment Associates's Adient position peaked at $835K in Q4 2017.
  • 401 funds tracked by Wall St. Rank held Adient as of Q1 2018.

Based on Sit Investment Associates's 13F filing for Q1 2018, filed 20 Apr 2018.